Trexquant Investment’s State Street Health Care Select Sector SPDR ETF XLV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-6,896
Closed -$888K 1857
2023
Q3
$888K Buy
+6,896
New +$916K 0.02% 794
2022
Q3
Sell
-6,925
Closed -$888K 1891
2022
Q2
$888K Buy
6,925
+2,046
+42% +$268K 0.04% 564
2022
Q1
$668K Buy
+4,879
New +$646K 0.03% 636
2021
Q4
Sell
-15,663
Closed -$1.99M 1676
2021
Q3
$1.99M Buy
15,663
+11,393
+267% +$1.51M 0.16% 173
2021
Q2
$538K Sell
4,270
-5,511
-56% -$675K 0.05% 471
2021
Q1
$1.14M Buy
+9,781
New +$1.13M 0.1% 248
2020
Q4
Sell
-34,521
Closed -$3.64M 1557
2020
Q3
$3.64M Buy
34,521
+18,613
+117% +$1.96M 0.23% 110
2020
Q2
$1.59M Sell
15,908
-18,929
-54% -$1.87M 0.11% 258
2020
Q1
$3.09M Buy
+34,837
New +$3.38M 0.22% 116
2019
Q4
Sell
-5,574
Closed -$502K 1299
2019
Q3
$502K Buy
+5,574
New +$509K 0.04% 452

Other funds holding XLV

Trexquant Investment's XLV Position: Q4 2023 in Review

Trexquant Investment sold out of State Street Health Care Select Sector SPDR ETF (XLV) in Q4 2023, closing a stake of 6,896 shares — an estimated $888K sold.

Trexquant Investment first reported a position in XLV in Q3 2019 and held it in 10 quarters. The position peaked at $3.64M in Q3 2020. 1,641 funds tracked by Wall St. Rank hold XLV as of Q4 2023.

  • Trexquant Investment reported no remaining State Street Health Care Select Sector SPDR ETF position as of Q4 2023 after selling out during the quarter.
  • Trexquant Investment sold 6,896 State Street Health Care Select Sector SPDR ETF shares in Q4 2023, an estimated $888K.
  • Trexquant Investment first reported a position in State Street Health Care Select Sector SPDR ETF in Q3 2019 and held it in 10 quarters.
  • Trexquant Investment's State Street Health Care Select Sector SPDR ETF position peaked at $3.64M in Q3 2020.
  • 1,641 funds tracked by Wall St. Rank held State Street Health Care Select Sector SPDR ETF as of Q4 2023.

Based on Trexquant Investment's 13F filing for Q4 2023, filed 9 Feb 2024.